Net shares · 365d
-336.4K
0 buy · 336.4K sell
Net value · 365d
-$5.4M
$0 in · $5.4M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
9
0 buy · 336.4K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
19.5K sh · 4 lots
Own +16%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$695.1K
39.7K sh · $17.49
Own -14%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$172.8K
19.5K sh · $8.85 avg · 4 lots
Own +7%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
2.3K sh
Own +3%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$340.0K
22.6K sh · $15.07
Own -8%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$9.4K
2.3K sh · $3.99
Own +1%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$430.7K
30.6K sh · $14.08
Own -10%
-
ADPT Sell·S
Chief People Officer
$574.5K
38.1K sh · $15.09
Own -11%
-
ADPT Grant·A
Chief People Officer
$0
44.1K sh
Own +14%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
79.6K sh · 4 lots
Own +720%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$614.0K
79.6K sh · $7.71 avg · 4 lots
Own +25%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$1.4M
79.6K sh · $17.73
Own -20%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
3.1K sh
Own +3%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$12.5K
3.1K sh · $3.99
Own +1%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$50.2K
3.1K sh · $16.08
Own -1%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
4.4K sh · 3 lots
Own +4%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$26.6K
4.4K sh · $6.06 avg · 3 lots
Own +1%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$76.9K
4.4K sh · $17.50
Own -1%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
4.4K sh · 3 lots
Own +4%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$31.5K
4.4K sh · $7.18 avg · 3 lots
Own +1%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$76.9K
4.4K sh · $17.50
Own -1%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$0
97.0K sh · 3 lots
Own +738%
-
ADPT Exercise·M
Chief People Officer · 10b5-1
$617.8K
97.0K sh · $6.37 avg · 3 lots
Own +29%
-
ADPT Sell·S
Chief People Officer · 10b5-1
$1.8M
113.9K sh · $15.57
Own -26%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | ADPT | Exercise M | 19.5K4 lots | $0 |
| Jun 4, 2026 | ADPT | Sell S | 39.7K | $695.1K |
| Jun 4, 2026 | ADPT | Exercise M | 19.5K4 lots | $172.8K |
| Apr 8, 2026 | ADPT | Exercise M | 2.3K | $0 |
| Apr 8, 2026 | ADPT | Sell S | 22.6K | $340.0K |
| Apr 8, 2026 | ADPT | Exercise M | 2.3K | $9.4K |
| Mar 11, 2026 | ADPT | Sell S | 30.6K | $430.7K |
| Mar 5, 2026 | ADPT | Sell S | 38.1K | $574.5K |
| Mar 4, 2026 | ADPT | Grant A | 44.1K | $0 |
| Jan 12, 2026 | ADPT | Exercise M | 79.6K4 lots | $0 |
| Jan 12, 2026 | ADPT | Exercise M | 79.6K4 lots | $614.0K |
| Jan 12, 2026 | ADPT | Sell S | 79.6K | $1.4M |
| Jan 2, 2026 | ADPT | Exercise M | 3.1K | $0 |
| Jan 2, 2026 | ADPT | Exercise M | 3.1K | $12.5K |
| Jan 2, 2026 | ADPT | Sell S | 3.1K | $50.2K |
| Dec 22, 2025 | ADPT | Exercise M | 4.4K3 lots | $0 |
| Dec 22, 2025 | ADPT | Exercise M | 4.4K3 lots | $26.6K |
| Dec 22, 2025 | ADPT | Sell S | 4.4K | $76.9K |
| Dec 22, 2025 | ADPT | Exercise M | 4.4K3 lots | $0 |
| Dec 22, 2025 | ADPT | Exercise M | 4.4K3 lots | $31.5K |
| Dec 22, 2025 | ADPT | Sell S | 4.4K | $76.9K |
| Dec 15, 2025 | ADPT | Exercise M | 97.0K3 lots | $0 |
| Dec 15, 2025 | ADPT | Exercise M | 97.0K3 lots | $617.8K |
| Dec 15, 2025 | ADPT | Sell S | 113.9K | $1.8M |
Buy Sell Non-market (grant · exercise · gift)
About LO FRANCIS
This profile aggregates every SEC Form 4 insider transaction reported by LO FRANCIS across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.